Author

Cristoforo Incorvaia

Cardiac/Pulmonary Rehabilitation, ASST Gaetano Pini/CTO, Milan, Italy - Cited by 10,300 - Allergy - pulmonology

Biography

Cristoforo Incorvaia is currently working as a Professor in the Department of Cardiac/Pulmonary. His research interests includes Medicine. He is serving as an editorial member and reviewer of several international reputed journals. He has successfully completed his Administrative responsibilities. He has authored of many research articles/books related to Medicine.
Title
Cited by
Year
Cabbage and fermented vegetables: from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19
J Bousquet, JM Anto, W Czarlewski, T Haahtela, SC Fonseca, G Iaccarino, ...Allergy 76 (3), 735-750, 2021202
108
2021
Nrf2‐interacting nutrients and COVID‐19: time for research to develop adaptation strategies
J Bousquet, JP Cristol, W Czarlewski, JM Anto, A Martineau, T Haahtela, ...Clinical and translational allergy 10 (1), 58, 2020202
57
2020
Personalized medicine for allergy treatment: allergen immunotherapy still a unique and unmatched model
C Incorvaia, M Al‐Ahmad, IJ Ansotegui, S Arasi, C Bachert, C Bos, ...Allergy 76 (4), 1041-1052, 2021202
31
2021
Urticaria: recommendations from the Italian Society of allergology, asthma and clinical immunology and the Italian society of allergological, occupational and environmental …
E Nettis, C Foti, M Ambrifi, I Baiardini, L Bianchi, A Borghi, M Caminati, ...Clinical and Molecular Allergy 18 (1), 1-19, 2020202
29
2020
Allergic reactions to genus Morus plants: a review
F Papia, C Incorvaia, L Genovese, S Gangemi, PL MinciulloClinical and Molecular Allergy 18, 1-5, 2020202
15
2020
SIRM-SIAAIC consensus, an Italian document on management of patients at risk of hypersensitivity reactions to contrast media
MT Costantino, L Romanini, F Gaeta, F Stacul, RL Valluzzi, M Passamonti, ...Clinical and Molecular Allergy 18, 1-10, 2020202
15
2020
Mabs for treating asthma: omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab
E Ridolo, F Pucciarini, MC Nizi, E Makri, P Kihlgren, L Panella, ...Human Vaccines & Immunotherapeutics 16 (10), 2349-2356, 2020202
15
2020
Recovery of smell sense loss by mepolizumab in a patient allergic to Dermatophagoides and affected by chronic rhinosinusitis with nasal polyps
C Cavaliere, C Incorvaia, F Frati, D Messineo, M Ciotti, A Greco, ...Clinical and Molecular Allergy 17, 1-4, 2019201
13
2019
The spectrum of therapeutic activity of mepolizumab
C Cavaliere, F Frati, E Ridolo, A Greco, M de Vincentiis, S Masieri, ...Expert Review of Clinical Immunology 15 (9), 959-967, 2019201
12
2019
Long-term omalizumab efficacy in allergic rhinitis
C Cavaliere, E Begvarfaj, C Incorvaia, B Sposato, M Brunori, A Ciofalo, ...Immunology Letters 227, 81-87, 2020202
12
2020
Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better …
T Zuberbier, T Dörr, W Aberer, M Alvaro, E Angier, S Arasi, H Arshad, ...Allergy 77 (6), 1736-1750, 2022202
11
2022
International consensus statement on allergy and rhinology: Allergic rhinitis–2023
SK Wise, C Damask, LT Roland, C Ebert, JM Levy, S Lin, A Luong, ...International forum of allergy & rhinology 13 (4), 23-85, 2023202
9
2023
Large local reaction to Hymenoptera stings: Sound studies are needed to change a shared concept
S Pucci, C Incorvaia, A RomanoImmunity, Inflammation and Disease (4), 258-259, 2019201
7
2019
Subcutaneous and sublingual allergen-specific immunotherapy: a tale of two routes.
C Incorvaia, G Ciprandi, MC Nizi, E Makri, E RidoloEuropean Annals of Allergy and Clinical Immunology 52 (6), 245-25, 2020202
7
2020
The safety of carbamylated monomeric allergoids for sublingual immunotherapy. Data from a pharmacovigilance study
E Compalati, C Incorvaia, S Urbano, P Strada, F FratiImmunotherapy 12 (3), 195-202, 2020202
6
2020
Efficacy of dupilumab in concomitant atopic dermatitis and chronic rhinosinusitis with nasal polyps: a preliminary study
E Nettis, V Patella, R Brancaccio, C Detoraki, E Di Leo, C Incorvaia, ...Allergy, Asthma & Immunology Research 13 (2), 347, 2021202
6
2021
Personalized medicine and allergen immunotherapy: the beginning of a new era?
C Incorvaia, E Ridolo, D Bagnasco, S Scurati, GW CanonicaClinical and Molecular Allergy 19 (1), 1-, 2021202
6
2021
A bio-psycho-social approach in elderly population: Outcome of adapted physical activity in patients with osteoarthritis
L Panella, C Incorvaia, AV Caserta, O Amata, D Consonni, L Pessina, ...La Clinica Terapeutica 171 (1), e74-e77, 2020202
6
2020
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life
E Nettis, L Brussino, V Patella, L Bonzano, A Detoraki, E Di Leo, ...Clinical and Molecular Allergy 20 (1), , 2022202
6
2022
Role of frailty in functional recovery after hip fracture, the variable impact in restoring autonomy
O Amata, L Panella, C Incorvaia, A Tomba, F Gervasoni, AV Caserta, ...Acta Bio Medica: Atenei Parmensis 92 (6), 2022202
5
2022

Referred From: https://scholar.google.com/citations?hl=en&user=0DZ4Ld0AAAAJ

Cited by
Citations 10300
h-index 50
i10-index 218
Recommended Journals
Open Access Journals